| Company Name: |
Riedel-de Haen AG
|
| Tel: |
800 558-9160 |
| Email: |
|
| Products Intro: |
Remarks:affinity isolated antibody, buffered aqueous solution
|
|
| | ANTI-C-FMS Basic information |
| Product Name: | ANTI-C-FMS | | Synonyms: | ANTI-C-FMS;Anti-CD115 antigen;Anti-CSF1R antibody produced in rabbit;Anti-Fms proto-oncogene;Anti-Macrophage colony-stimulating factor 1 receptor precursor;Anti-CSF1R antibody produced in goat;Colony stimulating factor 1 receptor | | CAS: | | | MF: | | | MW: | 0 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File | ![ANTI-C-FMS Structure]() |
| | ANTI-C-FMS Chemical Properties |
| storage temp. | -20°C | | form | buffered aqueous glycerol solution |
| Hazard Codes | Xn | | Risk Statements | 22 |
| | ANTI-C-FMS Usage And Synthesis |
| Uses | Anti-CSF1R antibody has been used:
- in cell lysis
- in immunoprecipitation
- in western blotting
- in immunohistochemical analysis
| | General Description | CSF1R (Colony stimulating factor 1 receptor), a type III receptor tyrosine kinase, is a member of the platelet-derived growth factor (PDGF) receptor family. Structurally, it is composed of five immunoglobulin-like domains, a transmembrane domain, a juxtamembrane domain (JM) and a protein kinase domain separated into two parts by an insert domain (KID). | | Biochem/physiol Actions | CSF1R (Colony stimulating factor 1 receptor) is a major molecule in the innate immunity, cancer, and inflammatory diseases, including systemic lupus erythematosus, arthritis, atherosclerosis and obesity. It regulates developmental activities including cell survival, proliferation, differentiation, and function of mononuclear phagocytes. It has been reported that CSF-1 autocrine loop helps to activate macrophages. In actual state, it exists as an autoinhibited form, and upon activation, it dimerizes. Later, it autophosphorylates tyrosine residues in the intracellular domain, followed by the recruitment of signaling molecules as well as internalization of the receptor. Mutation in the CSF1R causes several diseases including myeloid malignancies. |
| | ANTI-C-FMS Preparation Products And Raw materials |
|